Post by NEMERA

Nemera was delighted to join Montagu’s Annual General Meeting, with our CEO Marc Hämel presenting our story and ambitions to investors. And what a nice surprise (and a privilege!) to discover Nemera referred to as a “trophy asset”. We’ll take the compliment and try to keep our feet firmly on the ground! 🙂 We were proud to contribute to the conversations alongside other portfolio companies and to be part of such a dynamic ecosystem. Together with Montagu, we are fully committed to accelerating our development as a leading, patient-driven player in drug delivery. Thank you to Montagu for hosting such an inspiring event, and to Marc Hämel for highlighting the work and ambition of all Nemera teams. A moment of pride for all of us!